Xometry (NASDAQ:XMTR) Reaches New 12-Month High - What's Next?

Key Points

• Xometry shares reached a new 52-week high of $51.87, closing at $51.79, with a trading volume of 686,881 shares.
• Analyst ratings for Xometry are predominantly positive, with six analysts rating it as a Buy and an average target price of $40.44, reflecting a recent upgrade from several investment firms.
• The company reported earnings per share of $0.09 for the last quarter, exceeding estimates and marking a revenue increase of 22.6% year-on-year.

Xometry, Inc. (NASDAQ:XMTR - Get Free Report)'s stock price hit a new 52-week high on Tuesday . The company traded as high as $51.87 and last traded at $51.79, with a volume of 686881 shares. The stock had previously closed at $49.68.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on XMTR shares. JPMorgan Chase & Co. boosted their price target on Xometry from $36.00 to $38.00 and gave the stock an "overweight" rating in a research report on Tuesday, June 3rd. Cantor Fitzgerald raised Xometry from an "underweight" rating to a "neutral" rating and set a $41.00 price target for the company in a research report on Tuesday, August 5th. Citigroup reissued an "outperform" rating on shares of Xometry in a research report on Friday, July 11th. The Goldman Sachs Group boosted their price objective on Xometry from $33.00 to $42.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Finally, UBS Group boosted their price objective on Xometry from $35.00 to $40.00 and gave the stock a "neutral" rating in a research report on Wednesday, August 6th. Six analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $40.44.

Xometry Stock Up 4.2%

The company has a debt-to-equity ratio of 1.20, a current ratio of 3.91 and a quick ratio of 3.85. The stock has a market capitalization of $2.63 billion, a P/E ratio of -42.11 and a beta of 0.87. The firm has a 50 day moving average of $40.28 and a 200-day moving average of $32.41.

Xometry (NASDAQ:XMTR - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of $0.05 by $0.04. Xometry had a negative return on equity of 6.79% and a negative net margin of 10.20%.The company had revenue of $162.55 million for the quarter, compared to analyst estimates of $156.53 million. During the same period in the prior year, the company posted ($0.01) EPS. The company's revenue was up 22.6% compared to the same quarter last year. Xometry has set its Q3 2025 guidance at EPS. On average, equities research analysts expect that Xometry, Inc. will post -0.66 earnings per share for the current fiscal year.

Insider Activity at Xometry

In other Xometry news, CEO Randolph Altschuler sold 9,332 shares of the company's stock in a transaction on Wednesday, July 2nd. The stock was sold at an average price of $32.39, for a total transaction of $302,263.48. Following the transaction, the chief executive officer owned 319,602 shares of the company's stock, valued at approximately $10,351,908.78. This represents a 2.84% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO James Miln sold 598 shares of the company's stock in a transaction on Tuesday, September 2nd. The stock was sold at an average price of $50.25, for a total value of $30,049.50. Following the transaction, the chief financial officer directly owned 144,115 shares in the company, valued at approximately $7,241,778.75. This represents a 0.41% decrease in their position. The disclosure for this sale can be found here. 9.66% of the stock is owned by insiders.

Institutional Trading of Xometry

Several hedge funds have recently added to or reduced their stakes in the business. Corebridge Financial Inc. grew its holdings in shares of Xometry by 1.6% in the 1st quarter. Corebridge Financial Inc. now owns 21,481 shares of the company's stock valued at $535,000 after acquiring an additional 348 shares in the last quarter. Advisors Asset Management Inc. lifted its stake in Xometry by 68.3% in the 2nd quarter. Advisors Asset Management Inc. now owns 1,015 shares of the company's stock valued at $34,000 after purchasing an additional 412 shares during the last quarter. Zevenbergen Capital Investments LLC lifted its stake in Xometry by 5.1% in the 1st quarter. Zevenbergen Capital Investments LLC now owns 10,250 shares of the company's stock valued at $255,000 after purchasing an additional 500 shares during the last quarter. The Manufacturers Life Insurance Company lifted its stake in Xometry by 3.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 20,615 shares of the company's stock valued at $697,000 after purchasing an additional 608 shares during the last quarter. Finally, GAMMA Investing LLC lifted its stake in Xometry by 160.1% in the 1st quarter. GAMMA Investing LLC now owns 1,004 shares of the company's stock valued at $25,000 after purchasing an additional 618 shares during the last quarter. Institutional investors and hedge funds own 97.31% of the company's stock.

About Xometry

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.